Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis Advanced analysis of neuroimaging features associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results